Baye Tiruneh Amsalu, Gebeyehu Hamelmal, Bekele Mahteme, Abdelmenan Semira, Ashengo Tigistu Adamu, Mengistu Berhanu
Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.
Department of Internal Medicine, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Cost Eff Resour Alloc. 2024 Apr 4;22(1):25. doi: 10.1186/s12962-024-00530-7.
The treatment of kidney disease, including hemodialysis, poses challenges in healthcare and finances. Despite limited data on hemodialysis costs and determinants in Ethiopia, existing literature indicates a paucity of evidence regarding the economic burden of hemodialysis. This study aims to evaluate the direct and indirect costs of hemodialysis among end-stage renal disease (ESRD) patients, alongside associated factors, among selected governmental and private institutions in Addis Ababa, Ethiopia.
An institutional-based cross-sectional study using a simple random sampling technique was conducted from September 10 to November 1, 2021. One hundred twenty-eight patients participated in the study. Data was collected using an interviewer-administered questionnaire. The analysis used proportion and frequency measures of central tendency and linear regression measures. Both simple and multiple linear regression models were used to assess associated factors. The final model used a P value < 0.05 at 95% confidence interval (CI) was used to determine significance.
The mean cost of hemodialysis in a representative sample of selected hospitals in Addis Ababa was 7,739.17 $ ±2,833.51 $, with direct medical cost contributing 72.9% of the total cost. Furthermore, the institution type (private or public) and duration on hemodialysis were associated with an increased cost of hemodialysis.
Our findings underline the necessity for policymakers, program administrators, and healthcare institution executives to prioritize this group, recognizing the substantial load they bear and extending these services in government facilities to a broader patient population.
肾脏疾病的治疗,包括血液透析,在医疗保健和财务方面都带来了挑战。尽管埃塞俄比亚关于血液透析成本及其决定因素的数据有限,但现有文献表明,关于血液透析经济负担的证据匮乏。本研究旨在评估埃塞俄比亚亚的斯亚贝巴选定的政府和私立机构中终末期肾病(ESRD)患者血液透析的直接和间接成本以及相关因素。
于2021年9月10日至11月1日采用简单随机抽样技术进行了一项基于机构的横断面研究。128名患者参与了该研究。通过访谈员管理的问卷收集数据。分析使用了集中趋势的比例和频率测量以及线性回归测量。简单和多元线性回归模型均用于评估相关因素。最终模型在95%置信区间(CI)下使用P值<0.05来确定显著性。
亚的斯亚贝巴选定医院的代表性样本中血液透析的平均成本为7739.17美元±2833.51美元,直接医疗成本占总成本的72.9%。此外,机构类型(私立或公立)和血液透析持续时间与血液透析成本增加相关。
我们的研究结果强调,政策制定者、项目管理者和医疗机构管理人员有必要优先关注这一群体,认识到他们所承受的巨大负担,并将政府设施中的这些服务扩展到更广泛的患者群体。